Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Pamidronate (ATC M05BA03) issued by DAK-Gesundheit in Hamburg, Germany, valid from January 1, 2027, to December 31, 2028, with an option to extend for an additional 12 months.
Scope Of Work: The DAK-Gesundheit intends to establish a framework discount agreement under § 130a Abs. 8 SGB V for the active ingredient Pamidronate (ATC M05BA03). This agreement will allow pharmaceutical companies to enter into discount contracts for medications covered by statutory health insurance. The contracts will commence on January 1, 2027, and conclude on December 31, 2028, with a possibility of a 12-month extension. Interested bidders must submit proposals detailing the medications they wish to include, with specific documentation required by the DAK-Gesundheit.
Qualification Criterion: To qualify, bidders must submit the following documents by email to DAK-Gesundheit: a proposal letter, acknowledgment of contractual terms including the specified discounts, and completed annexes detailing the medications. These documents must be sent in electronic format, specifically as an Excel file for Annex 2. Submissions must be received by the 5th of the month preceding the desired contract start date. Late submissions may still allow for future participation at designated times.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |